Telios Pharma, Inc. Report issue

For profit Phase 2
Founded: San Diego CA United States (2019)

Organization Overview

First Clinical Trial
2020
NCT04419623
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Telios Pharma, Inc.